| Primary |
| Erectile Dysfunction |
58.6% |
| Drug Use For Unknown Indication |
29.1% |
| Hypertension |
3.0% |
| Product Used For Unknown Indication |
2.3% |
| Blood Cholesterol Increased |
0.9% |
| Unevaluable Event |
0.8% |
| Sexual Dysfunction |
0.7% |
| Depression |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Diabetes Mellitus |
0.5% |
| Atrial Fibrillation |
0.5% |
| Anxiety |
0.4% |
| Prostatomegaly |
0.4% |
| Glaucoma |
0.3% |
| Libido Decreased |
0.3% |
| Blood Pressure Abnormal |
0.2% |
| Gout |
0.2% |
| Hiv Infection |
0.2% |
| Hypercholesterolaemia |
0.2% |
| Pain |
0.2% |
|
| Erectile Dysfunction |
29.7% |
| Drug Ineffective |
17.7% |
| Adverse Event |
8.6% |
| Headache |
8.1% |
| Erection Increased |
4.1% |
| Nasal Congestion |
3.6% |
| Flushing |
3.4% |
| No Adverse Event |
3.0% |
| Visual Disturbance |
3.0% |
| Vision Blurred |
2.8% |
| Drug Use For Unknown Indication |
2.7% |
| Visual Acuity Reduced |
1.9% |
| Drug Effect Decreased |
1.9% |
| Tinnitus |
1.8% |
| Nausea |
1.5% |
| Visual Impairment |
1.4% |
| Ocular Hyperaemia |
1.2% |
| Dizziness |
1.2% |
| Visual Field Defect |
1.2% |
| No Adverse Drug Effect |
1.1% |
|
| Secondary |
| Erectile Dysfunction |
58.7% |
| Drug Use For Unknown Indication |
15.4% |
| Hypertension |
3.9% |
| Ill-defined Disorder |
3.1% |
| Diabetes Mellitus |
3.0% |
| Blood Cholesterol Increased |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Sexual Dysfunction |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Pain |
1.1% |
| Unevaluable Event |
1.1% |
| Ulcer |
1.0% |
| Atrial Fibrillation |
0.9% |
| Dyspnoea |
0.9% |
| Fatigue |
0.9% |
| Scleroderma |
0.9% |
| Skin Ulcer |
0.9% |
| Anxiety |
0.7% |
| Convulsion |
0.7% |
| Back Pain |
0.6% |
|
| Erectile Dysfunction |
46.1% |
| Drug Ineffective |
8.1% |
| Adverse Event |
6.9% |
| Drug Use For Unknown Indication |
5.2% |
| Headache |
4.7% |
| Nasal Congestion |
3.5% |
| Vision Blurred |
3.4% |
| Flushing |
2.5% |
| Nausea |
2.3% |
| Visual Acuity Reduced |
2.2% |
| Therapeutic Response Unexpected |
2.0% |
| Visual Impairment |
1.8% |
| Grand Mal Convulsion |
1.5% |
| Optic Ischaemic Neuropathy |
1.5% |
| Rash Macular |
1.5% |
| Upper Respiratory Tract Infection |
1.5% |
| Rhinorrhoea |
1.3% |
| Spontaneous Penile Erection |
1.3% |
| Unevaluable Event |
1.3% |
| No Adverse Event |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.9% |
| Drug Use For Unknown Indication |
13.6% |
| Erectile Dysfunction |
10.7% |
| Hiv Infection |
6.1% |
| Pain |
5.2% |
| Hypertension |
5.0% |
| Depression |
4.9% |
| Diabetes Mellitus |
4.7% |
| Multiple Myeloma |
3.8% |
| Multiple Sclerosis |
3.0% |
| Parkinson's Disease |
3.0% |
| Type 2 Diabetes Mellitus |
2.7% |
| Rheumatoid Arthritis |
2.3% |
| Blood Cholesterol Increased |
2.3% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Atrial Fibrillation |
1.8% |
| Hepatitis C |
1.8% |
| Blood Testosterone Decreased |
1.5% |
| Hypercholesterolaemia |
1.3% |
| Osteoporosis |
1.3% |
|
| Myocardial Infarction |
12.3% |
| Vomiting |
8.9% |
| Weight Decreased |
8.5% |
| Drug Ineffective |
6.8% |
| Wheezing |
6.0% |
| Transient Ischaemic Attack |
5.5% |
| Pancreatitis |
4.7% |
| Rash |
4.7% |
| Type 2 Diabetes Mellitus |
4.3% |
| Erectile Dysfunction |
3.8% |
| Hepatitis |
3.8% |
| Thrombocytopenia |
3.8% |
| Visual Acuity Reduced |
3.8% |
| Weight Increased |
3.8% |
| Pathological Gambling |
3.4% |
| Suicidal Ideation |
3.4% |
| Vision Blurred |
3.4% |
| Metastases To Liver |
3.0% |
| Tooth Infection |
3.0% |
| White Blood Cell Count Increased |
3.0% |
|
| Interacting |
| Hiv Infection |
45.7% |
| Erectile Dysfunction |
28.6% |
| Hypertension |
8.6% |
| Anxiety |
5.7% |
| Pain |
5.7% |
| Blood Pressure |
2.9% |
| Bronchitis |
2.9% |
|
| Hypertension |
23.1% |
| Heart Rate Increased |
15.4% |
| Septic Shock |
15.4% |
| Visual Acuity Reduced |
15.4% |
| Drug Interaction |
7.7% |
| Pain In Extremity |
7.7% |
| Scotoma |
7.7% |
| Sinus Tachycardia |
7.7% |
|
